Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Safran S.A.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-65.5% vs price
Base Case (Median)
-61.7% vs price
Bull Case (75th pct.)
-23.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $36.48 | -64.2% | High (40%) |
| PE Comparable | $94.42 | -7.2% | Medium (25%) |
| Growth Trajectory DCF | $334.03 | 228.2% | Medium (20%) |
| Graham Number | $33.74 | -66.9% | High (80%) |
| EV/EBITDA | $38.99 | -61.7% | Medium (20%) |
| EV/FCF | $61.57 | -39.5% | Medium (20%) |
| Earnings Power Value | $14.12 | -86.1% | High (70%) |
Based on 7 out of 7 methods, SAFRY appears overvalued at the current price of $101.79. The base case fair value of $38.99 implies 61.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.